Contracts Associate

Company description: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Job description: At OXB, our people are at the heart of everything we do. Were on a mission to enable life-changing therapies to reach patients around the worldand were looking for passionate individuals who embody our core values every day:?Responsible, Responsive, Resilient, and Respectful. Were currently recruiting for a Contracts Associate to join our Legal Team. In this role you will be drafting, reviewing and negotiating basic agreements with third parties and assisting with contract management. Your responsibilities in this role would be: Liaise with Legal Team members relating to the preparation and dispatch of agreements with third parties. Draft, review and negotiate agreements in accordance with company policies and procedures and business requirements. Assist the Legal Team with the management of processes and procedures relating to agreement requests, drafting, negotiation and finalisation. Support in creating training materials and processes for internal clients and other members of the Legal Team. With the assistance of Legal Team, undertake review of proposed terms and conditions and develop strategies and recommendations to minimize potential risks to the business. Keep track of status of unsigned agreements and follow up where necessary. Handover of agreement to internal contract requesters to explain obligations, risks and timing of notice provisions. Contribute at regular Legal Team meetings and triage of Contracts inbox and Legal Team inbox requests for legal and contractual support. Filing of electronic correspondence and agreements on legal databases. Assist Legal Team in keeping OXB agreement templates and policies up to date. Profile description: We are looking for: A scientific, legal or other degree and experience working in a legal support role Demonstrable experience of generation, review, negotiation and management of basic agreements with other parties including confidential disclosure, consultancy and service agreements. Proficiency in MS Word, Excel and Adobe, with demonstrable database knowledge and understanding Experience of working with internal and external customers Some appreciation in the use of AI within the workplace. Ability to prioritise workload & work to deadlines and manage multiple work streams with attention to detail Confident communicator, able to interact at all levels both within the company and externally About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the worlds most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXBs world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. Why Join Us? ???Competitive total reward packages ???Wellbeing programmes?that support your mental and physical health ???Career development opportunities?to help you grow and thrive ???Supportive, inclusive, and collaborative culture ???State-of-the-art labs and manufacturing facilities ?? A company that lives its values:?Responsible, Responsive, Resilient, Respect We want you to feel inspired every day. At OXB, were future-focused and growing fast. We succeed togetherthrough passion, commitment, and teamwork. Ready to Make a Difference? Collaborate. Contribute. Change lives. We offer: Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patients cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. TPBN1_UKTJ

Created: 2025-12-12